CPRIT PDR — Texas New Technologies Company
Funds Texas oncology startups in emerging technologies, including digital and life science manufacturing pathways.
The Cancer Prevention and Research Institute of Texas (CPRIT) operates the Texas New Technologies Company RFA as part of its Product Development Research program, which allocates approximately $70 million per fiscal year to Texas-based oncology companies. This track specifically serves oncology-enabling technologies that do not fit the Therapeutics or Device/Diagnostics RFAs — covering bioinformat…
Oncology-enabling technologies — bioinformatics, AI, radionuclides, cell-based therapy manufacturing, sample quality tools, and biomanufacturing — not fitting the therapeutics or device tracks.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline